Drugs / SHP-141C
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01646567 | Sep → Nov 2012 | psoriasis | TetraLogic Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SHP-141C | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01646567 ↗ |